Market evolution: Patient monitors (CN 90181910) — 2015–2025

Introduction

This report analyses the evolution of EU external trade in patient monitors — electro-diagnostic apparatus for the simultaneous monitoring of two or more physiological parameters (customs code 90181910) — over the period 2015–2025. The EU has historically been a strong net exporter of these high-value medical devices, but the decade under review reveals a structural erosion of that position. Three main dynamics stand out: a persistent decline in export volumes and values, a significant reorientation of trade partners — most notably the rise of China as an import source — and a strong upward shift in unit prices alongside a dramatic expansion of domestic production.

1. A steadily eroding trade surplus

The EU's trade surplus in patient monitors has narrowed considerably over the decade. While the Union remains a net exporter, the gap between exports and imports has tightened on every metric — value, volume, and unit price.

1.1 Export values and volumes have fallen sharply

Between the first and last year of the dataset, EU exports of patient monitors to non-EU countries declined from €820.8 million to €672.8 million (−18.0%), and export volumes dropped even more steeply, from 2,328 tonnes to 1,552 tonnes (−33.3%). The peak export year saw values reach €1,144.4 million — likely during the COVID-19 demand surge — but the sector has since given back those gains. The trade overview shows that the 2025 level is the lowest in the entire period for both value and volume.

1.2 Imports have trended upward despite volatility

EU imports tell a different story. Import values rose from €277.9 million to €329.8 million (+18.7%), with a peak of €597.5 million during the pandemic period. Import volumes grew more modestly, from 1,745 tonnes to 1,893 tonnes (+8.4%), having peaked at 3,454 tonnes. The fact that import values grew faster than volumes points to rising unit import prices.

1.3 The trade surplus contracted by more than a third

Combining these trends, the EU's trade balance in patient monitors fell from €542.9 million in 2015 to €343.0 million in 2025 — a contraction of 36.8%. The net import reliance indicator confirms this trend: it moved from −37.9% to −17.1% (negative values indicate net exporter status). While the EU still exports more than it imports, the margin has thinned substantially — a shift of 55% toward import reliance.

Source: Trade overview, Net import reliance

2. Geographic reorientation of trade flows

Behind the headline figures lie significant shifts in the EU's trade geography. China's role has been transformed — rising sharply as an import source and falling as an export destination — while EU exporter concentration has increased and import sources have diversified.

2.1 China became a dominant import supplier, then partially receded

The most dramatic geographic shift concerns China. EU imports from China surged from €41.6 million in 2015 to a peak of €283.7 million — a near-sevenfold increase — before settling back to €92.4 million in 2025. Even at this reduced level, the 2025 figure represents a 122.1% increase over 2015 and makes China the largest single import source. This boom-and-partial-bust cycle is consistent with the COVID-19 pandemic driving an extraordinary demand spike for medical monitoring equipment, much of which was sourced from Chinese manufacturers. The import partner data confirms that China's volatility is the highest among major import sources, with a coefficient of variation of 0.60.

Meanwhile, other traditional import sources have declined:

Source: Import partners

2.2 EU export markets have become more concentrated

On the export side, the EU's concentration index (HHI) for exports by value rose from 2,255 to 2,595 (+15.1%), indicating growing reliance on fewer destination markets. The United States remains the dominant export partner by a wide margin, absorbing €332.0 million of EU exports in 2025 (down from €373.9 million in 2015, −11.2%). The United Kingdom held steady around €55 million. By contrast, exports to China collapsed by 73.2% (from €58.8M to €15.8M), and exports to Türkiye fell by 51.1%.

Source: Export partners

2.3 The Netherlands consolidated its role as the EU's main hub

Among EU Member States, the Netherlands has emerged as the dominant export hub, accounting for €438.5 million in exports in 2025 (65% of total EU exports). Notably, Finnish exports collapsed by 72.1% (from €139.2M to €38.8M) and Danish exports fell 66.1%, suggesting that production and distribution in these countries has contracted or shifted elsewhere. On the import side, Germany remained the largest importer (€150.7M, +8.3%), but the Netherlands showed the fastest growth (+126.1%, from €37.9M to €85.7M), alongside strong increases in Poland (+120.9%) and Italy (+65.3%).

Finland remains the most specialised EU producer in patient monitors, with a Revealed Symmetric Comparative Advantage (RSCA) of 0.79 and an RCA of 8.74, followed by Germany (RCA 2.25) and the Netherlands (RCA 1.74).

3. Rising unit prices and an expanding production base

A third defining feature of this market is the simultaneous rise in export unit values and a reported explosion in EU production volumes — trends that, together, suggest a structural shift in the product mix and manufacturing landscape.

3.1 Export unit prices rose by nearly 23% while import prices also climbed

Despite falling export volumes, the EU managed to sustain higher unit prices. Export prices (value per tonne) rose from €352,475/t to €433,314/t (+22.9%). Import prices also increased, though less dramatically, from €159,156/t to 174,230/t (+9.5%). The persistent price gap — EU exports at roughly 2.5 times the import unit value — reflects the EU's position in the higher-end segment of the patient monitor market.

The price shock analysis reveals a notable import price shock from China in 2021 (abnormality score 49.7, value share 39.3%), coinciding with the peak of COVID-19-driven demand. This suggests that the extraordinary surge in Chinese imports was accompanied by atypical pricing, likely reflecting supply chain stress and surging demand.

Source: Trade overview

3.2 Domestic production volumes expanded dramatically

According to PRODCOM data, EU production of patient monitors (mapped to code 26.60.12.80) surged from 3.4 million items (valued at €2.0 billion) in 2015 to 30 million items (valued at €4.0 billion) in 2025 — a quantity increase of 778% and a value increase of 97.5%. The peak year saw production of 993.5 million items, an extraordinary figure that warrants cautious interpretation and may reflect reporting anomalies or the inclusion of lower-cost devices.

The divergence between quantity growth (+778%) and value growth (+98%) implies that the average unit production price fell sharply over the period — from approximately €594 per item to €133 per item. This could reflect the mass production of simpler, lower-cost monitoring devices (e.g., pulse oximeters or single-purpose wearables classified under the same residual code), the scaling up of manufacturing capacity during and after COVID-19, or shifts in reporting practices.

3.3 Export propensity strengthened while trade intensity grew

The EU's export propensity — the ratio of exports to domestic production — rose from 104.6% to 160.8% (+53.7%), meaning that the EU now exports a significantly larger share of its output than it did a decade ago. Similarly, trade intensity increased from 102.6% to 124.7% (+21.5%). These indicators, taken together, suggest that the patient monitor sector has become more globally integrated: the EU produces more but also trades a greater share of that production internationally, specialising in higher-value segments while importing mid- and low-range devices.

Conclusion

Over 2015–2025, the EU patient monitor market underwent a structural transformation. The EU's trade surplus, while still positive, shrank by more than a third as export volumes declined faster than import volumes grew. Geographically, China emerged as a major import source — peaking during the COVID-19 crisis — while EU export markets became more concentrated around the United States. Unit prices for EU exports rose, consistent with a shift toward higher-value devices, while domestic production appears to have expanded massively in volume terms, potentially reflecting the scaling of lower-cost monitoring equipment.

The net effect is a sector that is more globally integrated, more exposed to import competition (particularly from Asia), and increasingly reliant on a narrow set of export destinations. For EU policymakers, the key challenge going forward will be to sustain the Union's competitive edge in the high-end segment of the market while managing the risks associated with growing import dependence and concentrated export exposure.